Friday, August 07, 2026 | 10:16 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 35 - Vaccine

Russia likely to start Covid-19 mass vaccination from January 1, 2021

Teachers and medical workers will be the first to get the Covid-19 vaccine jointly developed by the Gamaleya Research Institute and the Russian Defence Ministry

Russia likely to start Covid-19 mass vaccination from January 1, 2021
Updated On : 11 Aug 2020 | 7:39 PM IST

We are looking at vaccines as new growth pivot: Strides Pharma chief

In a Q&A, pharma major's MD & CEO, R Ananthanarayanan says the firm is setting up a vaccine suite and is in final-stage talks with global players to seal a deal for developing a Covid-19 vaccine

We are looking at vaccines as new growth pivot: Strides Pharma chief
Updated On : 07 Aug 2020 | 11:35 PM IST

Large-scale US Covid-19 vaccine trials will exclude pregnant women for now

Drugmakers say they first need to make sure the vaccines are safe and effective more generally

Large-scale US Covid-19 vaccine trials will exclude pregnant women for now
Updated On : 01 Aug 2020 | 1:45 PM IST

GSK profit misses as vaccine sales disappoint, stockpiling eases

The company said it still expects adjusted earnings per share for the year to decline in the range of 1% to 4%

GSK profit misses as vaccine sales disappoint, stockpiling eases
Updated On : 29 Jul 2020 | 9:23 PM IST

Why vaccines can't be launched overnight

Under normal circumstances, the development of new vaccines and treatments could take 10-20 years

Why vaccines can't be launched overnight
Updated On : 16 Jul 2020 | 10:06 PM IST

India's 1st indigenously developed vaccine against pneumonia gets DCGI nod

The Serum Institute of India first obtained the approval of the DCGI to conduct Phase I, II and III clinical trials of the vaccine in India

India's 1st indigenously developed vaccine against pneumonia gets DCGI nod
Updated On : 15 Jul 2020 | 9:05 PM IST

Lakshmi Mittal gifts GBP 3.5 mn to Oxford for developing Covid-19 vaccine

Lakshmi Mittal said, "This year has been a wake-up call to the world to be better prepared for pandemics, which, as we have all experienced, can cause massive social and economic disruption."

Lakshmi Mittal gifts GBP 3.5 mn to Oxford for developing Covid-19 vaccine
Updated On : 10 Jul 2020 | 9:36 PM IST

UK begins trial of latest virus vaccine this week with 300 candidates

The British government said 300 healthy people will be immunized with two doses of the Covid-19 vaccine candidate developed at Imperial, which has been backed by 41 million pounds

UK begins trial of latest virus vaccine this week with 300 candidates
Updated On : 16 Jun 2020 | 7:59 AM IST

AstraZeneca agrees to supply Europe with 400 mn doses of Covid-19 vaccine

The deal is the latest by AstraZeneca to pledge supply of its vaccine to governments who have scrambled to agree advance purchases of promising coronavirus vaccines

AstraZeneca agrees to supply Europe with 400 mn doses of Covid-19 vaccine
Updated On : 14 Jun 2020 | 6:57 AM IST

WHO calls for more research on asymptomatic transmission of Covid-19

Saying that the world has been achieving a lot in knowing the new virus, the WHO chief told reporters that "there's still a lot we don't know"

WHO calls for more research on asymptomatic transmission of Covid-19
Updated On : 11 Jun 2020 | 9:15 AM IST

Lilly Covid-19 treatment could be authorised by September: Chief Scientist

Lilly has already launched human trials with two of the experimental therapies

Lilly Covid-19 treatment could be authorised by September: Chief Scientist
Updated On : 11 Jun 2020 | 8:36 AM IST

Panacea forms JV with Refana to develop, manufacture Covid-19 vaccine

The firm is set to make 500 million doses of the vaccine, which will then be supplied to the JV (based in the Republic of Ireland).

Panacea forms JV with Refana to develop, manufacture Covid-19 vaccine
Updated On : 10 Jun 2020 | 10:08 PM IST

Gilead's remdesivir slows disease progression in monkeys with Covid-19

Remdesivir did not show signs of respiratory disease and had reduced damage to the lungs

Gilead's remdesivir slows disease progression in monkeys with Covid-19
Updated On : 09 Jun 2020 | 6:21 PM IST

What are antibody therapies and who is developing them for Covid-19?

Eli Lilly is collaborating with Junshi and Canadian biotech firm AbCellera Biologics to develop different antibody treatments

What are antibody therapies and who is developing them for Covid-19?
Updated On : 09 Jun 2020 | 3:03 PM IST

World coronavirus dispatch: Work on vaccine globalised like never before

From how lockdown has changed human behavior, to New Zealand becoming Covid-free, and how coronavirus devastated the diamond world - read these and more in today's world dispatch

World coronavirus dispatch: Work on vaccine globalised like never before
Updated On : 08 Jun 2020 | 5:53 PM IST

World Coronavirus Dispatch: Is Brazil trying to hide the true toll numbers?

Meanwhile, India enters the list of top 5 infected nations; European airlines set to resume operations

World Coronavirus Dispatch: Is Brazil trying to hide the true toll numbers?
Updated On : 07 Jun 2020 | 4:37 PM IST

India coronavirus dispatch: How Covid spreads from a contaminated surface

From five lessons India should learn from the crisis, to state of sport post-Covid, read these and more in today's India dispatch

India coronavirus dispatch: How Covid spreads from a contaminated surface
Updated On : 07 Jun 2020 | 4:25 PM IST

WHO finally endorses masks to prevent transmission

Since the beginning of the pandemic, surprisingly, the WHO had refused to endorse masks

WHO finally endorses masks to prevent transmission
Updated On : 07 Jun 2020 | 12:22 AM IST

Serum Institute risks making Covid vaccine before trial at new $100 mn unit

AstraZeneca deal with SII is for supply of a billion doses, with a commitment to provide 400 mn before 2020-end. If all goes well, India could have its first set of Covid-19 vaccines by end of year

Serum Institute risks making Covid vaccine before trial at new $100 mn unit
Updated On : 06 Jun 2020 | 3:36 AM IST

India joins global alliance to support vaccine supply, immunisation

Gavi's routine immunisation efforts, including during the course of the coronavirus pandemic, help stop the spread of infectious diseases and the resurgence of other epidemics

India joins global alliance to support vaccine supply, immunisation
Updated On : 05 Jun 2020 | 9:33 AM IST